Synthesis and enzymatic cleavage of dual-ligand quantum dots

Materials Science and Engineering C

Volumn 29, Issue 4, 2009, Pages 1428-1432

  Sewell, Sarah L ^a   Giorgio, Todd D ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Dual ligand; MMP 7; Nanotechnology; Quantum dot; Targeted therapy; Tissue specific targeting

Indexed keywords

CANCER-TARGETING; CELL SURFACE RECEPTORS; CURRENT LIMITATIONS; CYTOTOXIC AGENTS; DUAL-LIGAND; ENZYMATIC CLEAVAGES; FLUOROMETRIC ANALYSIS; FOLATE LIGANDS; FOLIC ACIDS; FUNCTIONALIZED; IN-VIVO; MATRIX METALLOPROTEASE; MMP-7; MOLECULAR RECOGNITION MECHANISMS; NANO STRUCTURES; NON-SPECIFIC BINDINGS; NORMAL TISSUES; PATHOLOGIC TISSUES; POLY(ETHYLENE GLYCOL); QUANTUM DOT; SMALL MOLECULES; SPECIFIC BINDINGS; TARGET CELLS; TARGETED DELIVERIES; TARGETED THERAPY; TARGETING SYSTEMS; THERAPEUTIC INDICES; TUMOR TISSUES;

AGENTS; AMINES; CELL MEMBRANES; CHELATION; ETHYLENE; ETHYLENE GLYCOL; HISTOLOGY; INTERNET; LIGANDS; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NANOPARTICLES; NANOTECHNOLOGY; OPTICAL WAVEGUIDES; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SYNTHESIS (CHEMICAL); TUMORS; ULSI CIRCUITS;

SEMICONDUCTOR QUANTUM DOTS;

EID: 64949119269     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2008.11.015     Document Type: Article

References (39)

1. Sachdeva M.S. Expert Opin. Investig. Drugs 7 (1998) 1849
2. Hallahan D.E., Geng L., Cmelak A.J., Charkravarthy A.B., Martin W., Scarfone C., and Gonzalez A. J. Control. Release 74 (2001) 183
3. Pastorino F., Brignole C., Marimpietri D., Cilli M., Gambini C., Ribatti D., Longhi R., Allen T.M., Corti A., and Ponzoni M. Cancer Res. 63 (2003) 7400
4. Mitra A., Mulholland J., Nan A., McNeill E., and Ghandehari H. J. Control. Release 102 (2005) 191
5. Bogenrieder T., and Herlyn M. Oncogene 22 (2003) 6524
6. Kim R., and Toge T. Surg. Today 34 (2004) 293
7. Weissleder R., Tung C.-H., Mahmood U., and Bogdanov A. Nat. Biotechnol. 17 (1999) 375
8. Tung C.-H., Mahmood U., Bredow S., and Weissleder R. Cancer Res. 60 (2000)
9. McIntyre J.O., and Matrisian L.M. J. Cell. Biochem. 90 (2003) 1087
10. Harris T.D., von Maltzahn G., Derfus A.M., Ruoslahti E., and Bhatia S. Angew. Chem., Int. Ed. 45 (2006) 3161
11. Yao H., Zhang Y., Xiao F., Xia Z., and Rao J. Angew. Chem., Int. Ed. 46 (2007) 4346
12. McIntyre J.O., Fingleton B., Wells S.K., Piston D.W., Lynch C.C., Gautam S., and Matrisian L.M. Biochem. J. 377 (2004) 617
13. Suzawa T., Nagamura S., Saito H., Ohta S., Hanai N., Kanazawa J., Okabe M., and Yamasaki M. J. Control. Release 79 (2002) 229
14. Suzawa T., Nagamura S., Salto H., Ohta S., Hanai N., and Yamasaki M. J. Control. Release 69 (2000) 27
15. Lui C., Sun C., Huang H., Janda K., and Edgington T. Cancer Res. 63 (2003) 2957
16. Basset P., O.A., Chenard M.P., Kannan R., Stoll I., Anglard P., Bellocp J.P., and Rio M.C. Matrix Bio. 15 (1997) 535
17. Johnsen M., Lund L.R., Romer J., Almholt K., and Dano K. Curr. Opin. Cell Biol. 10 (1998)
18. Bachmeier B.E., Nerlich A.G., Lichtinghagen R., and Sommerhoff C.P. Anticancer Res. 21 (2001) 3821
19. Tanimoto H., Underwood L.J., Shigemasa K., Parmley T.H., Wang Y., Yan Y., Clarke J., and O'Brien T.J. Tumor Biol. 20 (1999) 88
20. Vihinen P., and Kahari V.-M. Int. J. Cancer 99 (2002) 157
21. Yamamoto H., Adachi Y., Itoh F., Iku S., Matsuno K., Kusano M., Arimura Y., Endo T., Hinoda Y., Hosokawa M., and NasaoImai K. Cancer Res. 59 (1999) 3313
22. Yamamoto H., Itoh F., Iku S., Adachi Y., Fukishima H., Sasaki S., Mukaiya M., Hirata K., and Imai K. J. Clin. Oncol. 19 (2001) 1118
23. Crawford H.C., Scoggins C.R., Washington M.K., Matrisian L.M., and Leach S.D. J. Clin. Invest. 109 (2002) 1437
24. Hulboy D.L., Gautam S., Fingleton B., and Matrisian L.M. Oncol. Rep. 12 (2004) 13
25. Smith R.A., Sewell S.L., and Giorgio T.D. J. of Inter. Nanomed. 3 (2008) 95-103
26. Ballou B., Langerholm B.C., Ernst L.A., Bruchez M.P., and Waggoner A.S. Bioconjug. Chem. 16 (2004) 1488
27. Bentzen E.L., Tomlinson I.D., Mason J., Gresch P., Warnement M.R., Wright D., Sanders-Bush E., Blakely R., and Rosenthal S.J. Bioconjug. Chem. 16 (2005) 1488
28. Pan D., Turner J.L., and Wooley K.L. Chem. Commun. (2003) 2400
29. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigaveka S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., Baker J., and James R. Cancer Res. 65 (2005) 5317
30. Parker N., Turk M.J., Westrick E., Lewis J.D., Low P.S., and Leamon C.P. Anal. Biochem. 338 (2005) 284
31. Hartmann L.C., Keeney G.L., Lingle W.L., Christianson T.J.H., Varghese B., and Hillman D. Int. J. Cancer 121 (2007) 938
32. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R., and Kamen B.A. Cancer Res. 52 (1992) 3396
33. Holm J., Hansen S.I., Hoier-Madsen M., and Bostad L. Biochem. J. 280 (1991) 267
34. Kennedy M.D., Jallad K.N., Lu J., Low P.S., and Ben-Amotz D. Pharm. Res. 20 (2003) 714
35. Patrick T.A., Kranz D.M., van Dyke T.A., and Roy E.J. J. Neuro-Oncol. 32 (1997) 111
36. Hermanson G.T. Bioconjugate Techniques (1996), Academic Press, San Diego
37. Derfus A.M.C., Alice A., Min D.-H., Ruoslahti E., and Bhatia S.N. Bioconjug. Chem. 18 (2007) 1391
38. Kioi M., Yamamoto K., Higashi S., Koshikawa N., Fujita K., and Miyazaki K. Oncogene 22 (2003) 8662
39. Wang F.-Q., So J., Reierstad S., and Fishman D.A. Int. J. Cancer 114 (2005) 19